ロード中...
Antiplatelet Therapy for Stroke Prevention in Atrial Fibrillation
Warfarin has been the cornerstone therapy for stroke prevention in non-valvular atrial fibrillation (NVAF), particularly in patients at high risk of ischemic stroke or thromboembolism. Warfarin use in NVAF results in a 64% relative reduction in the incidence of ischemic stroke and several trials hav...
保存先:
| 出版年: | Mo Med |
|---|---|
| 主要な著者: | , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Journal of the Missouri State Medical Association
2010
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6192815/ https://ncbi.nlm.nih.gov/pubmed/20222295 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|